Most SLE/SS-associated autoantibodies detected in iMCD patients targeted La (n = 10, 10%), Ro60 (n = 5, 5%), and Sm/RNP (n = 4, 4%) (w 1D). Here, RNPC3 is linked to synovial sarcoma.